Patents by Inventor Jinhwa Lee

Jinhwa Lee has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11663469
    Abstract: A method for controlling an artificial intelligent (AI) device providing a travel service, and which includes learning, via a processer of the AI device, a plurality of daily patterns related with a user's wake-up time, a commuting time, and a travel route using a deep neural networks (DNN) model; determining, via the processor, whether the daily patterns satisfy predetermined conditions each time a corresponding daily pattern among the plurality of daily patterns is generated; determining, via the processor, that the user is currently traveling when at least one daily pattern among the plurality of daily patterns that does not satisfy the predetermined conditions is detected; setting, via the processor, a time when the at least one daily pattern that does not satisfy the predetermined conditions is detected for a first time as a starting point of travel; setting, via the processor, a time from the starting point of the travel to an end point of the travel as a travel period of the user when an end of the use
    Type: Grant
    Filed: February 20, 2020
    Date of Patent: May 30, 2023
    Assignee: LG ELECTRONICS INC.
    Inventors: Jinhwa Hong, Soojin Lee, Ilhwan Choi, Munho Yun, Sunghyun Park
  • Patent number: 11649255
    Abstract: The present disclosure provides a compound of Formula (I) or pharmaceutically acceptable salts thereof, a composition comprising the compound, methods of using the compound for the treatment of various disorders associated with HPK1, and methods of preparing these compounds.
    Type: Grant
    Filed: September 27, 2021
    Date of Patent: May 16, 2023
    Assignee: 1ST Biotherapeutics, Inc.
    Inventors: Jinhwa Lee, Suyeon Jo, Keonseung Lim, A Yeong Park, Gadhe Changdev Gorakshnath, Hwajung Nam, Yeonguk Jeon, Yejin Hwang, Jae Eun Kim, Misoon Kim, Seung Mook Lim
  • Publication number: 20220242861
    Abstract: The present disclosure provides a compound of Formula (I) or pharmaceutically acceptable salt, stereoisomers thereof, a pharmaceutical composition comprising the compound, and a method to treat or prevent cancer diseases and/or proliferative disorders using the compound.
    Type: Application
    Filed: February 21, 2020
    Publication date: August 4, 2022
    Inventors: Jinhwa LEE, Suyeon JO, Keonseung LIM, A Yeong PARK, Jae Eun KIM, Misoon KIM, Inyoung YANG
  • Publication number: 20220177463
    Abstract: The present disclosure provides polymorphic forms and salts of (1S,2S)-2-fluoro-N-(6-(4-methylpyridin-3-yl)benzo[d]thiazol-2-yl)cyclopropane-1-carboxamide, pharmaceutical compositions comprising the compounds, processes for preparation of the compounds, and methods for treating neurodegenerative disorders.
    Type: Application
    Filed: March 27, 2020
    Publication date: June 9, 2022
    Inventors: Jinhwa LEE, Suyeon JO
  • Publication number: 20220160902
    Abstract: The present disclosure relates to [18F]-labeled benzothiazole derivatives or salts thereof as positron emission tomography (PET) radiotracers suitable for imaging the stress-signaling non-receptor tyrosine kinase c-abl, and their use in in vivo diagnosis, preclinical and clinical imaging, patient stratification on the basis of mutational status of c-abl and assessing response to therapeutic treatments. The present disclosure further relates to the use of [18F]-labeled benzothiazole derivatives as PET radiotracers. The disclosure also provides a process for the radiosynthesis of [18F]-labeled benzothiazole derivatives.
    Type: Application
    Filed: March 6, 2020
    Publication date: May 26, 2022
    Inventors: Jinhwa LEE, Suyeon JO
  • Publication number: 20220098219
    Abstract: The present disclosure provides a compound of Formula (I) or pharmaceutically acceptable salts thereof, a composition comprising the compound, methods of using the compound for the treatment of various disorders associated with HPK1, and methods of preparing these compounds.
    Type: Application
    Filed: September 27, 2021
    Publication date: March 31, 2022
    Inventors: Jinhwa LEE, Suyeon JO, Keonseung LIM, A Yeong PARK, Gadhe Changdev GORAKSHNATH, Hwajung NAM, Yeonguk JEON, Yejin HWANG, Jae Eun KIM, Misoon KIM, Seung Mook LIM
  • Publication number: 20220098193
    Abstract: The present disclosure provides a compound of Formula (I) or pharmaceutically acceptable salts thereof, a composition comprising the compound, methods of using the compound for the treatment of various disorders associated with HPK1, and methods of preparing these compounds.
    Type: Application
    Filed: September 27, 2021
    Publication date: March 31, 2022
    Inventors: Jinhwa LEE, Suyeon JO, Keonseung LIM, A Yeong PARK, Gadhe Changdev GORAKSHNATH, Hwajung NAM, Yeonguk JEON, Yejin HWANG, Jae Eun KIM, Misoon KIM, Seung Mook LIM
  • Publication number: 20220087985
    Abstract: The present disclosure provides a compound of Formula (I) or pharmaceutically acceptable salt, stereoisomers thereof, a pharmaceutical composition comprising the compound, and a method for treating or preventing an inflammatory and autoimmune diseases, especially neuroinflammation diseases using the compound.
    Type: Application
    Filed: September 14, 2021
    Publication date: March 24, 2022
    Inventors: Jinhwa LEE, Suyeon JO, Keonseung LIM, A Yeong PARK, Gadhe Changdev GORAKSHNATH, Hwajung NAM, Yeonguk JEON, Yejin HWANG, Jae Eun KIM, Misoon KIM, Inyoung YANG
  • Publication number: 20210347774
    Abstract: The present disclosure provides a compound of Formula (I) or pharmaceutically acceptable salt, stereoisomers thereof, a pharmaceutical composition comprising the compound, and a method to treat or prevent neurodegenerative diseases using the compound.
    Type: Application
    Filed: July 12, 2021
    Publication date: November 11, 2021
    Inventors: Jinhwa LEE, Suyeon JO, Keonseung LIM, A Yeong PARK, Jae Eun KIM, Misoon KIM, Seung Mook LIM
  • Patent number: 11098044
    Abstract: The present disclosure provides a compound of Formula (I) or pharmaceutically acceptable salt, stereoisomers thereof, a pharmaceutical composition comprising the compound, and a method to treat or prevent neurodegenerative diseases using the compound.
    Type: Grant
    Filed: February 21, 2020
    Date of Patent: August 24, 2021
    Assignee: 1ST Biotherapeutics, Inc.
    Inventors: Jinhwa Lee, Suyeon Jo, Keonseung Lim, A Yeong Park, Jae Eun Kim, Misoon Kim, Seung Mook Lim
  • Patent number: 10968188
    Abstract: The present disclosure provides a compound of general Formula (I) having c-abl kinase inhibitory activity or pharmaceutically acceptable salt thereof, a pharmaceutical composition comprising the compound, and a method useful to treat or prevent neurodegenerative diseases using the compound.
    Type: Grant
    Filed: May 14, 2020
    Date of Patent: April 6, 2021
    Assignee: 1st Biotherapeutics, Inc.
    Inventors: Jinhwa Lee, Suyeon Jo, A Yeong Park, Gwibin Lee, Jae Eun Kim, Misoon Kim, Gyooseung Jung, Seung Mook Lim, Keonseung Lim, Minwoo Lee, Heekyoung Yang, Hyonam Kim, Hyeongjun Kim, Wanjun Li, Mingzhu Fan
  • Publication number: 20200270222
    Abstract: The present disclosure provides a compound of general Formula (I) having c-abl kinase inhibitory activity or pharmaceutically acceptable salt thereof, a pharmaceutical composition comprising the compound, and a method useful to treat or prevent neurodegenerative diseases using the compound.
    Type: Application
    Filed: May 14, 2020
    Publication date: August 27, 2020
    Inventors: Jinhwa LEE, Suyeon JO, A Yeong PARK, Gwibin LEE, Jae Eun KIM, Misoon KIM, Gyooseung JUNG, Seung Mook LIM, Keonseung LIM, Minwoo LEE, Heekyoung YANG, Hyonam KIM, Hyeongjun KIM, Wanjun LI, Mingzhu FAN
  • Publication number: 20200270246
    Abstract: The present disclosure provides a compound of Formula (I) or pharmaceutically acceptable salt, stereoisomers thereof, a pharmaceutical composition comprising the compound, and a method to treat or prevent neurodegenerative diseases using the compound.
    Type: Application
    Filed: February 21, 2020
    Publication date: August 27, 2020
    Inventors: Jinhwa LEE, Suyeon JO, Keonseung LIM, A Yeong PARK, Jae Eun KIM, Misoon KIM, Seung Mook LIM
  • Patent number: 10669246
    Abstract: The present disclosure provides a compound of general Formula (I) having c-abl kinase inhibitory activity or pharmaceutically acceptable salt thereof, a pharmaceutical composition comprising the compound, and a method useful to treat or prevent neurodegenerative diseases using the compound.
    Type: Grant
    Filed: October 1, 2018
    Date of Patent: June 2, 2020
    Assignee: 1ST Biotherapeutics, Inc.
    Inventors: Jinhwa Lee, Suyeon Jo, Gwibin Lee, Keonseung Lim, A Yeong Park, Wanjun Li, Mingzhu Fan
  • Patent number: 10385046
    Abstract: The present disclosure provides a process for preparing (1S,2S)-2-fluoro-N-(6-(4-methylpyridin-3-yl)benzo[d]thiazol-2-yl) cyclopropanecarboxamide or a salt thereof, such as the compound of Formula (I), comprising: reacting Compound 1 as a starting material with Compound 2 in the presence of Pd(dppf)Cl2 and 1,4-dioxane to form Compound 3; reacting Compound 3 with Compound 4 in the presence of HATU and DIPEA to produce Compound 5; and reacting Compound 5 with hydrochloric acid to produced Formula (I).
    Type: Grant
    Filed: March 19, 2019
    Date of Patent: August 20, 2019
    Assignee: 1ST Biotherapeutics, Inc.
    Inventors: Jinhwa Lee, Suyeon Jo
  • Publication number: 20190100500
    Abstract: The present disclosure provides a compound of general Formula (I) having c-abl kinase inhibitory activity or pharmaceutically acceptable salt thereof, a pharmaceutical composition comprising the compound, and a method useful to treat or prevent neurodegenerative diseases using the compound.
    Type: Application
    Filed: October 1, 2018
    Publication date: April 4, 2019
    Inventors: Jinhwa LEE, Jae Eun KIM, Suyeon JO, Gwibin LEE, Keonseung LIM, A Yeong PARK, Misoon KIM, Gyooseung JUNG, Seung Mook LIM, Minwoo LEE, Heekyoung YANG, Hyonam KIM, Hyeongjun KIM, Wanjun LI, Mingzhu FAN
  • Patent number: 9029389
    Abstract: The present invention refers to: a compound having the general formula (I), wherein n is 0, 1, 2 or; m is 0, 1, 2 or 3; o is 0, 1, 2 or 3; W, X, Y and Z are independently selected from CH, N or N-oxide; A is NR4, C?O, C?S, OP(O)(O), P?O, CH2, or a heteroarly selected from the group consisting of (a), (b), (c), (d), (e), (f), (g); V is C?O, O, S, CH2, or NR5; as well as its use in treating inflammatory diseases such as asthma, COPD, inflammation post infection, arthritis, atherosclerosis, pain and dermatitis.
    Type: Grant
    Filed: April 20, 2012
    Date of Patent: May 12, 2015
    Assignees: Institut Pasteur Korea, Qurient Co. Ltd
    Inventors: Zaesung No, Jaeseung Kim, Sung-Jun Han, Jung Hwan Kim, Young Sam Park, Sangchul Lee, Kiyean Nam, Jeongjun Kim, Jinhwa Lee, Sunhee Kang, Min Jung Seo, Saeyeon Lee, Gahee Choi
  • Patent number: 9006187
    Abstract: The present invention relates to a novel compound with thiophene ring having an inhibitory activity against sodium-dependent glucose cotransporter 2 (SGLT2) being present in the intestine and kidney, and a pharmaceutical composition comprising the same as an active ingredient, which is useful for preventing or treating metabolic disorders, particularly diabetes. The prevention also provides a method for preparing same, a pharmaceutical composition containing same, and a method for preventing or treating metabolic disorders, particularly diabetes.
    Type: Grant
    Filed: September 9, 2011
    Date of Patent: April 14, 2015
    Assignee: Green Cross Corporation
    Inventors: Jinhwa Lee, Kwang-Seop Song, Suk Ho Lee
  • Patent number: 8895558
    Abstract: The present invention relates to novel arylpiperazine-containing pyrrole 3-carboxamide derivatives of formula (I) or a pharmaceutically acceptable salt thereof which is useful for preventing or treating depressive disorders. The present invention also provides a method for preparing the arylpiperazine-containing pyrrole 3-carboxamide derivatives or the pharmaceutically acceptable salt thereof, a pharmaceutical composition containing same, and a method for preventing or treating depressive disorders.
    Type: Grant
    Filed: September 23, 2009
    Date of Patent: November 25, 2014
    Assignee: Green Cross Corporation
    Inventors: Jinhwa Lee, Suk Youn Kang, Eun-Jung Park, Kwang-Seop Song, Min Ju Kim, Hee Jeong Seo, Suk Ho Lee, Jeongmin Kim, Ae Nim Pae, Woo-Kyu Park
  • Patent number: 8835436
    Abstract: A novel arylpiperazine-containing imidazole 4-carboxamide derivative or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition comprising the same as an active ingredient for preventing or treating a depressive disorder are provided.
    Type: Grant
    Filed: July 9, 2010
    Date of Patent: September 16, 2014
    Assignee: Green Cross Corporation
    Inventors: Jinhwa Lee, Hee Jeong Seo, Suk Youn Kang, Eun-Jung Park, Min Ju Kim, Suk Ho Lee, Jong Yup Kim, Jeongmin Kim, Myung Eun Jung, Hyun Jung Kim, Mi-soon Kim, Ho Kyun Han, Kwang Woo Ahn, Min Woo Lee, Ki-Nam Lee, Ae Nim Pae, Woo-Kyu Park